Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.

BIOMACROMOLECULES, published by the American Chemical Society, stands as a premier journal in the fields of bioengineering, biomaterials, materials chemistry, and polymers and plastics. With a commendable impact factor that places it in the Q1 category across these disciplines, it is recognized for its influential research contributions and is ranked strongly within its scopes—16th in Polymers and Plastics and 26th in Biomaterials according to Scopus. Since its inception in 2000 and continuing through 2024, the journal has been pivotal in disseminating significant findings and technological advancements that propel the field forward. Although it does not currently have an open access option, the journal offers invaluable insights that are essential for researchers, professionals, and students engaged in the cutting-edge exploration of macromolecules and their diverse applications. With its address located at 1155 16th St, NW, Washington, DC 20036, BIOMACROMOLECULES is not just a repository of knowledge but also a vital platform for fostering collaboration and innovation within the scientific community.

ACS Applied Bio Materials is a leading academic journal published by the American Chemical Society, focusing on the innovative intersection of bioengineering and materials science. Since its inception in 2018, the journal has established itself as a pivotal platform for disseminating impactful research within the fields of Biochemistry, Biomaterials, Biomedical Engineering, and Chemistry, often ranked in the top tiers of these categories. With an impressive impact factor, it holds a Q2 ranking in both Biochemistry and Biomaterials, and a prestigious Q1 ranking in Biomedical Engineering and miscellaneous Chemistry, underscoring its significance in advancing knowledge and practices across these disciplines. The journal’s editorial commitment to high-quality, peer-reviewed research ensures relevance and rigor, appealing to a diverse audience of researchers, professionals, and students keen to explore breakthroughs in bio-related materials technology. The access options enhance its visibility and reach, allowing for a broader dissemination of studies that drive innovation and collaboration in biotechnology and material sciences. Located in the heart of Washington, DC, ACS Applied Bio Materials serves as a crucial resource for advancing the future of healthcare, engineering, and materials research.

JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, published by SAGE PUBLICATIONS LTD, serves as a pivotal platform for disseminating innovative research in the fields of bioengineering, biomaterials, materials chemistry, and polymers. With an ISSN of 0883-9115 and an E-ISSN of 1530-8030, this journal is committed to the advancement of knowledge relating to the interaction of polymers within biological systems and their compatibility in various applications. Operating since 1986, the journal has garnered a respectable presence, ranked in the Q3 quartile across multiple categories in 2023, indicating its relevance and contribution to these dynamic fields. Although not open access, the journal ensures that high-quality research is accessible to subscribers and institutions, reinforcing its importance for researchers, professionals, and students aiming to stay abreast of advancements in polymer science and biocompatibility. By fostering interdisciplinary communication and collaboration, the JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS continues to play a crucial role in shaping the future of material applications in health, technology, and industry.

BIO-MEDICAL MATERIALS AND ENGINEERING, published by IOS PRESS, serves as a vital platform for advancing the fields of biomaterials and biomedical engineering. With its ISSN 0959-2989 and E-ISSN 1878-3619, the journal has been consistently disseminating high-quality research since its inception in 1991, covering a diverse range of studies on the development and application of biomedical materials. Although currently classified in the Q4 quartile in several categories including biomaterials and biomedical engineering, the journal aims to appeal to a broad audience of researchers and professionals, fostering collaboration and innovation in translating new materials into clinical practice. Located in the Netherlands, it emphasizes the importance of interdisciplinary approaches and provides a forum for new ideas and findings that could significantly impact healthcare solutions. While not an open-access journal, it provides various access options to maximize the reach and engagement of its research. Researchers, practitioners, and students alike will find valuable insights and comprehensive studies within its pages, contributing to the continued evolution of biomedical sciences.

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.

BIOMATERIALS, published by Elsevier Science Ltd, is a premier academic journal dedicated to the interdisciplinary field of biomaterials research. With an impressive impact factor, it ranks in the Q1 quartile across multiple categories including Bioengineering, Biomaterials, and Biophysics, showcasing its significance in advancing scientific knowledge. Established in 1980 and set to converge its discussions through 2025, this journal provides a critical platform for researchers and professionals to disseminate their findings on the development, application, and performance of biomaterials. The journal covers a wide range of topics, from the mechanics of materials to nanotechnology, and is highly regarded with top Scopus rankings in essential categories, including an exceptional position within the 99th percentile for Biophysics. Although not an open access journal, BIOMATERIALS remains vital for students and established researchers alike, ensuring accessibility to groundbreaking research in the field. Engage with cutting-edge studies that pave the way for innovative applications in medicine, engineering, and beyond.

The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, published by Wiley, is a leading journal in the field of biomaterials and biomedical engineering, with an impact factor reflected in its relevant Scopus rankings—including a Q2 position in Biomedical Engineering and Q3 in Biomaterials for 2023. This journal, with ISSN 1552-4973 and E-ISSN 1552-4981, serves as a vital platform for disseminating pioneering research and innovative applications of biomaterials. Positioned in the United States, it aims to bridge the gap between material science and biological applications, fostering collaboration among researchers, professionals, and students dedicated to advancing technology in healthcare. With a convergence of studies from 2003 to 2024 and a growing focus on open access, the journal ensures greater visibility and accessibility for groundbreaking research. Join us in exploring the dynamic field of biomaterials, as we push the boundaries of science and engineering for improved patient outcomes.

Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.